Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location.

A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location. | LitMetric

Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location.

Stefan Kasper Caroline Foch Regina Esser Francois-Xavier Lamy Aimar Zhang Ann-Lii Cheng Magali Rouyer Thomas Brodowicz Christoph Zielinski

Eur J Cancer

Comprehensive Cancer Centre, Vienna General Hospital and Medical University of Vienna, Austria.

Published: February 2023

Download full-text PDF
Source

http://dx.doi.org/10.1016/j.ejca.2022.11.021 DOI Listing

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ejca.2022.11.021	DOI Listing

Publication Analysis

Top Keywords

survival cetuximab

cetuximab every-2-weeks

every-2-weeks versus

versus standard

standard once-weekly

once-weekly administration

administration schedule

schedule first-line

first-line treatment

treatment ras

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!